Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences

S Moran, C Arribas, M Esteller - Epigenomics, 2016 - Taylor & Francis
Aim: DNA methylation is the best known epigenetic mark. Cancer and other pathologies
show an altered DNA methylome. However, delivering complete DNA methylation maps is …
被引用次数：683 相关文章

Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences.

S Moran, C Arribas, M Esteller - Epigenomics, 2015 - europepmc.org
Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome
enriched in enhancer sequences. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences

S Moran, C Arribas, M Esteller - Epigenomics, 2016 - cir.nii.ac.jp
抄録< jats: p> Aim: DNA methylation is the best known epigenetic mark. Cancer and other
pathologies show an altered DNA methylome. However, delivering complete DNA …
[HTML] nih.gov

[HTML][HTML] Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences

S Moran, C Arribas, M Esteller - Epigenomics, 2016 - ncbi.nlm.nih.gov
Aim: DNA methylation is the best known epigenetic mark. Cancer and other pathologies
show an altered DNA methylome. However, delivering complete DNA methylation maps is …

Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences

S Moran, C Arribas, M Esteller - Epigenomics, 2016 - hero.epa.gov
AIM: DNA methylation is the best known epigenetic mark. Cancer and other pathologies
show an altered DNA methylome. However, delivering complete DNA methylation maps is …
[PDF] semanticscholar.org

[PDF][PDF] Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences

S Moran, C Arribas, M Esteller - pdfs.semanticscholar.org
Aim: DNA methylation is the best known epigenetic mark. Cancer and other pathologies
show an altered DNA methylome. However, delivering complete DNA methylation maps is …

Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences

S Moran, C Arribas, M Esteller - Epigenomics, 2016 - pubmed.ncbi.nlm.nih.gov
Aim DNA methylation is the best known epigenetic mark. Cancer and other pathologies
show an altered DNA methylome. However, delivering complete DNA methylation maps is …

Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences

S Moran, C Arribas, M Esteller - Epigenomics, 2016 - search.proquest.com
Aim: DNA methylation is the best known epigenetic mark. Cancer and other pathologies
show an altered DNA methylome. However, delivering complete DNA methylation maps is …

Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences

S Moran, C Arribas, M Esteller - Epigenomics, 2016, vol. 8, num. 3, p …, 2016 - diposit.ub.edu
DNA methylation is the best known epigenetic mark. Cancer and other pathologies show an
altered DNA methylome. However, delivering complete DNA methylation maps is …

Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences.

S Moran, C Arribas, M Esteller - Epigenomics, 2015 - europepmc.org
Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome
enriched in enhancer sequences. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …